Recording High Frequency Oscillations in Patients With Tumors and Epilepsy
NCT ID: NCT02320136
Last Updated: 2023-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
120 participants
OBSERVATIONAL
2014-06-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to show that recording of high-frequency oscillations (HFOs) is feasible in our project population both intraoperatively and during presurgical physiological conditions.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
epilepsy
epilepsy patients
cognitive testing
patients perform simple tasks like watching a video or memorizing items
tumor with epilepsy
tumor patients with epileptic seizures
cognitive testing
patients perform simple tasks like watching a video or memorizing items
tumor without epilepsy
tumor patients without epileptic seizures
cognitive testing
patients perform simple tasks like watching a video or memorizing items
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive testing
patients perform simple tasks like watching a video or memorizing items
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients fall into one of the patient groups: (1) Patients with symptomatic epilepsy with focal and/or secondary generalized seizures resistant to medication where a neurosurgical resection is considered as an intervention of epilepsy surgery. (2)Patients where a tumor is planned to be resected that has caused preoperative seizures. (3) Patients where a tumor is planned to be resected that has not caused preoperative seizures.
* Male and Female subjects 18 years to 99 years of age
* Written informed consent after participants' information
Exclusion Criteria
* known or suspected non-compliance, drug or alcohol abuse,
* enrolment into a clinical trial within last 4 weeks
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johannes Sarnthein, Prof Dr
Role: PRINCIPAL_INVESTIGATOR
Universitätsspital Zürich
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HFO
Identifier Type: -
Identifier Source: org_study_id